Medtech’s mini guide to…centralized and decentralized regulatory procedures
This article was originally published in Clinica
Executive Summary
The European Parliament is currently considering the merits and drawbacks of centralized and decentralized pharmaceutical-style procedures conducted through the European Medicines Agency for certain high-risk medical devices.